Changchun, China

Shuyan Li

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Changchun Institute of Biological Products, Ministry of Public Health. Active years: 2003-2005.

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2003-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Shuyan Li: Innovator in Vaccine Development

Introduction

Shuyan Li is a prominent inventor based in Changchun, China. She has made significant contributions to the field of vaccine development, particularly in the area of hepatitis A and measles vaccines. With a total of 2 patents, her work has the potential to impact public health positively.

Latest Patents

One of her latest patents is the "Freeze-dried hepatitis A attenuated live vaccine and its stabilizer." This invention relates to a lyophilized attenuated hepatitis A vaccine that can be stored at ambient temperature for extended periods. It also includes a method for producing the vaccine and a stabilizer that improves the thermostability of the vaccine during processing and storage. Another notable patent is the "Combined vaccine against both HAV and measles virus and method of producing it." This combined live vaccine is designed to prevent infections from both hepatitis A and measles without causing interference between the two viruses' antigenicity.

Career Highlights

Shuyan Li works at the Changchun Institute of Biological Products, which is part of the Ministry of Public Health. Her role at this esteemed institution allows her to focus on innovative vaccine research and development.

Collaborations

Some of her notable coworkers include Guangpu Li and Pengfu Wang, who contribute to her research efforts and collaborative projects.

Conclusion

Shuyan Li's work in vaccine innovation showcases her dedication to improving public health through scientific advancements. Her patents reflect her commitment to developing effective and stable vaccines for critical diseases.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…